TriSalus Life Sciences Inc.(TLSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TLSI TriSalus Life Sciences Inc.

Closed Good Friday 04-17 16:00:00 EDT

5.74

+0.01

+0.17%

盘后5.74

+0.000.00%

16:05 EDT

High5.80	Low5.26	Vol15.58K
Open5.73	D1 Closing5.73	Amplitude9.39%
Mkt Cap185.24M	Tradable Cap131.40M	Total Shares32.27M
T/O89.16K	T/O Rate0.07%	Tradable Shares22.89M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"TLSI","market":"US","secType":"STK","nameCN":"TriSalus Life Sciences Inc.","latestPrice":5.74,"timestamp":1744920000000,"preClose":5.73,"halted":0,"volume":15582,"hourTrading":{"tag":"盘后","latestPrice":5.74,"preClose":5.74,"latestTime":"16:05 EDT","volume":1,"amount":5.74,"timestamp":1744920308679},"delay":0,"floatShares":22892483,"shares":32272462,"eps":-1.31191,"marketStatus":"Closed Good Friday","change":0.01,"latestTime":"04-17 16:00:00 EDT","open":5.73,"high":5.8,"low":5.262,"amount":89163.0425,"amplitude":0.093892,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.31191,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":5.73,"preHourTrading":{"tag":"盘前","latestPrice":5.73,"preClose":5.73,"latestTime":"04:21 EDT","volume":1,"amount":5.73,"timestamp":1744878106936},"postHourTrading":{"tag":"盘后","latestPrice":5.74,"preClose":5.74,"latestTime":"16:05 EDT","volume":1,"amount":5.74,"timestamp":1744920308679},"volumeRatio":0.3492516022972945},"requestUrl":"/m/hq/s/TLSI","defaultTab":"news","newsList":[{"id":"2526105415","title":"VAREX IMAGING (VREX) Moves 16.5% Higher: Will This Strength Last?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526105415","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526105415?lang=en_us&edition=full_marsco","pubTime":"2025-04-10 23:33","pubTimestamp":1744299180,"startTime":"0","endTime":"0","summary":"VAREX IMAGING  shares soared 16.5% in the last trading session to close at $8.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 41.8% loss over the past four weeks.The upside can be attributed to relief-rally across global markets following the announcement of a 90-day pause on tariff hike by the United States.VAREX IMAGING is part of the Zacks Medical - Products industry. TriSalus Life Sciences, Inc. , another stock in the same industry, closed the last trading session 0.2% higher at $5.50. TLSI has returned 7.9% in the past month.For TriSalus Life Sciences, Inc. , the consensus EPS estimate for the upcoming report has changed -2% over the past month to -$0.20. This represents a change of +63% from what the company reported a year ago. TriSalus Life Sciences, Inc. currently has a Zacks Rank of #3 .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/varex-imaging-vrex-moves-16-153300586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","VREX","TLSI","BK4139"],"gpt_icon":0},{"id":"2526279393","title":"TriSalus Life Sciences, Inc. (TLSI) Soars 6.6%: Is Further Upside Left in the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526279393","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526279393?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 20:47","pubTimestamp":1744202820,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences, Inc.  shares soared 6.6% in the last trading session to close at $5.49. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 10.5% gain over the past four weeks.The recent surge in TriSalus Life Sciences Inc.'s shares can be attributed to its strong fourth quarter and full-year 2024 results, marked by 44% YoY revenue growth in the fourth quarter and 59% for the full year, driven by the TriNav Infusion System. The company reaffirmed 2025 guidance with expected sales growth of over 50%, gross margins exceeding 87%, and a path to positive EBITDA and cash flow in the second half of 2025. Investor sentiment is further supported by the commercial launch of TriNav LV, expansion through the DELIVER program, and a strong cash position bolstered by expected funding from OrbiMed.TriSalus Life Sciences, Inc. is part of the Zacks Medical - Products industry. Abbott , another stock in the same industry,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trisalus-life-sciences-inc-tlsi-124700060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SGXZ23171101.USD","LU0868494617.USD","BK4585","LU0234572021.USD","LU1721429741.USD","LU1721429402.USD","LU2237957902.USD","LU2133065610.SGD","LU1989763690.USD","BK4568","BK4504","LU0170899867.USD","BK4082","LU2112291526.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU1061106388.HKD","LU0266013472.USD","BK4533","LU1023059063.AUD","SG9999004303.SGD","LU1914381329.SGD","IE0002141913.USD","LU0122379950.USD","LU2468319806.SGD","SG9999002224.SGD","IE00B2B36J28.USD","ABT","LU2237957811.SGD","LU2089984988.USD","BK4588","TLSI","IE00BFTCPJ56.SGD","BK4581","IE00BJJMRZ35.SGD","BK4139","BK4592","LU1691799644.USD","IE0009355771.USD","LU1057294990.SGD","SG9999002232.USD","LU1989763427.SGD","BK4566"],"gpt_icon":0},{"id":"2523863900","title":"TriSalus Life Sciences-Identified Errors in Timing of Stock-Based Compensation Expense, Clinical Trial Related Expenses. Use of Incorrect Assumptions","url":"https://stock-news.laohu8.com/highlight/detail?id=2523863900","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523863900?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 05:59","pubTimestamp":1743199186,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB1JP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2523764639","title":"TriSalus Life Sciences Inc Files Non-Timely 10-K With U.S. SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2523764639","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523764639?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 05:59","pubTimestamp":1743199186,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB1JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2523663185","title":"TriSalus Life Sciences - Anticipates Annual Report Will Be Filed on or Before Fifteenth Calendar Day Following Prescribed Due Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2523663185","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523663185?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 05:59","pubTimestamp":1743199186,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB1JP:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2522504402","title":"TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2522504402","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522504402?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 23:29","pubTimestamp":1743175740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLSI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 28, 2025 11:29 ET (15:29 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI"],"gpt_icon":0},{"id":"2522535353","title":"Analysts’ Top Healthcare Picks: X4 Pharmaceuticals (XFOR), TriSalus Life Sciences (TLSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522535353","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522535353?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 02:50","pubTimestamp":1743101415,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on X4 Pharmaceuticals (XFOR – Research Report) and TriS...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-x4-pharmaceuticals-xfor-trisalus-life-sciences-tlsi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-x4-pharmaceuticals-xfor-trisalus-life-sciences-tlsi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSI","XFOR","BK4139","BK4137","HCSG"],"gpt_icon":0},{"id":"2522241379","title":"TriSalus Life Sciences Q4 2024 GAAP EPS $(0.40) Misses $(0.32) Estimate, Sales $8.26M Beat $8.12M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522241379","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522241379?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:31","pubTimestamp":1743075114,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.32) by 25 percent. This is a 74.36 percent increase over losses of $(1.56) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44511400/trisalus-life-sciences-q4-2024-gaap-eps-0-40-misses-0-32-estimate-sales-8-26m-beat-8-12m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI"],"gpt_icon":0},{"id":"2522256379","title":"TriSalus Life Sciences Inc - Reaffirms 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2522256379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522256379?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:30","pubTimestamp":1743075000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA4QX1ZX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2522379255","title":"TriSalus Life Sciences Q4 Revenue USD 8.261 Million VS. Ibes Estimate USD 8.12 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522379255","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522379255?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:30","pubTimestamp":1743075000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX1FCBEA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2522379216","title":"TriSalus Life Sciences Q4 Gross Profit USD 7.045 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522379216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522379216?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:30","pubTimestamp":1743075000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX1FCBEA:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2522265379","title":"TriSalus Life Sciences Q4 Basic EPS USD -0.4 VS. Ibes Estimate USD -0.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2522265379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522265379?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:30","pubTimestamp":1743075000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX1FCBEA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2522379271","title":"Press Release: TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522379271","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522379271?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:30","pubTimestamp":1743075000,"startTime":"0","endTime":"0","summary":"-- Revenues of $8.3 Million in Q4 and $29.4 Million for Full-Year 2024,Representing Growth of 44% And 59%, Respectively, Versus the Prior Year. -- Gross Margin of 85% and 86% for Q4 and Full-Year 2024. 20% Reduction in Operating Expenses, Positive EBITDA, and Positive Cash. \"We were also pleased to strengthen our Board of Directors with the additions of William Valle and Dr. Gary Gordon. Additionally, we want to sincerely thank Sean Murphy for his leadership in guiding the Company through the process of going public, a milestone that would not have been possible without his dedication and expertise. We are thrilled to welcome him back to the Board of Directors and look forward to his continued contributions to our success,\" concluded Ms. Szela.These new products are eligible for the same HCPCS reimbursement codes as existing TriNav products, which should enable seamless integration into current billing structures. The Company believes these expanded features","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2500361329.USD","BK4555","BK4099","BK4022","BK4139","SITC","BK4588","BK4604","CMS","BK4208","LU2637428348.USD","BK4080","BK4585","LU1894683348.USD","R","LU2346227817.USD","TM","TLSI","LU1894683264.USD","03160","BK4232","BK4231"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX","PVLA","SDST","CELC","KYTX","PENG","CLSD","SKYH","RANI","FBIO","ADCT","PRGS","LULU","RLMD","FEMY","BRZE","TSAT","AFMD","WGO","ANGO","ATAI","SLRN","CALC","GWH","FTCI","LNZA","MDAI","BHST","EDAP","SPWH","UNCY","IKT","INMB","FC","BW","NCNO","DARE","PVH","WBA","SGML","NUTX","GEVO","GOVX","INR","CRDL","NNOX","TLSI","WKSP","BCAB","REKR"],"gpt_icon":0},{"id":"2522805384","title":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522805384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522805384?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 21:00","pubTimestamp":1742994009,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TriSalus Life Sciences (TLSI – Research Report) and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4139","BBNX","BK4082","HCSG","TLSI"],"gpt_icon":0},{"id":"2522287414","title":"BRIEF-TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping","url":"https://stock-news.laohu8.com/highlight/detail?id=2522287414","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522287414?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 20:03","pubTimestamp":1742990615,"startTime":"0","endTime":"0","summary":"BRIEF-TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav Infusion System MappingMarch 26 (Reuters) - TriSalus Life Sciences Inc TLSI.O:TRISALUS LIFE SCIENCES ANNOUNCES NEW CMS HCPCS CODE F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q90IJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"gpt_icon":0},{"id":"2522874187","title":"TriSalus Life Sciences Announces New CMS Hcpcs Code for Trinav® Infusion System Mapping","url":"https://stock-news.laohu8.com/highlight/detail?id=2522874187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522874187?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 20:02","pubTimestamp":1742990529,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q90IJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2517515405","title":"TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of \"Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2517515405","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517515405?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 21:00","pubTimestamp":1741266000,"startTime":"0","endTime":"0","summary":"DENVER, March 06, 2025----TriSalus Life Sciences, Inc.  , TriSalus Life Sciences, which seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies and our investigational immunotherapy, announced today that company researchers received two JVIR Top Paper Awards for a recent publication, including the JVIR Editor’s Award for Distinguished Laboratory Investigation and the JVIR People’s Choice Award for Most Downloaded Articles. These awards will be presented at the 2025 Society for Interventional Radiology meeting in Nashville TN.This peer-reviewed study, titled \"Intra-arterial Pressure-Enabled Drug Delivery Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model\" highlighted the superior performance of the TriNav Infusion System in delivering Glass Microspheres into liver tumors when compared to delivery with a traditional microcatheter. The model used a transgenically modi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trisalus-life-sciences-announces-researchers-130000264.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","TLSI","TLSIW"],"gpt_icon":0},{"id":"2512010103","title":"ADVISORY-Dated alert on Trisalus Life Sciences entering credit agreement withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2512010103","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512010103?lang=en_us&edition=full_marsco","pubTime":"2025-02-19 21:04","pubTimestamp":1739970248,"startTime":"0","endTime":"0","summary":"ADVISORY-Dated alert on Trisalus Life Sciences entering credit agreement withdrawnAn alert on Trisalus Life Sciences Inc TLSI.O entering into a $50 million credit agreement has been withdrawn as it wa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA0AB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"gpt_icon":0},{"id":"2512419170","title":"TriSalus Life Sciences Inc - Enters Into $50 Million Credit Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2512419170","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512419170?lang=en_us&edition=full_marsco","pubTime":"2025-02-19 19:12","pubTimestamp":1739963534,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA0AB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSI","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.trisaluslifesci.com","stockEarnings":[{"period":"1week","weight":0.0342},{"period":"1month","weight":0.1255},{"period":"3month","weight":0.1643},{"period":"6month","weight":0.3699},{"period":"1year","weight":-0.4095},{"period":"ytd","weight":0.1457}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.023435},{"month":2,"riseRate":1,"avgChangeRate":0.048907},{"month":3,"riseRate":0.4,"avgChangeRate":-0.017625},{"month":4,"riseRate":0.6,"avgChangeRate":0.001846},{"month":5,"riseRate":0.25,"avgChangeRate":-0.054636},{"month":6,"riseRate":0.5,"avgChangeRate":-0.054945},{"month":7,"riseRate":0.75,"avgChangeRate":-0.008115},{"month":8,"riseRate":0.5,"avgChangeRate":-0.098456},{"month":9,"riseRate":0.5,"avgChangeRate":-0.081362},{"month":10,"riseRate":0.5,"avgChangeRate":-0.072481},{"month":11,"riseRate":0.75,"avgChangeRate":0.021715},{"month":12,"riseRate":0.5,"avgChangeRate":0.299794}],"exchange":"NASDAQ","name":"TriSalus Life Sciences Inc.","nameEN":"TriSalus Life Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TriSalus Life Sciences Inc.(TLSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TriSalus Life Sciences Inc.(TLSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TriSalus Life Sciences Inc.,TLSI,TriSalus Life Sciences Inc.股票,TriSalus Life Sciences Inc.股票老虎,TriSalus Life Sciences Inc.股票老虎国际,TriSalus Life Sciences Inc.行情,TriSalus Life Sciences Inc.股票行情,TriSalus Life Sciences Inc.股价,TriSalus Life Sciences Inc.股市,TriSalus Life Sciences Inc.股票价格,TriSalus Life Sciences Inc.股票交易,TriSalus Life Sciences Inc.股票购买,TriSalus Life Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TriSalus Life Sciences Inc.(TLSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TriSalus Life Sciences Inc.(TLSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction